glp-1 news nov 2025 ISPOR 2025: Exploring reasons for discontinuation Novo cuts GLP-1 prices 70%,

and healthy fats like olive oil, avocados, and nuts and seeds

doi: 10.2337/dc20-2014

"The comment period for the proposed rule closed on June 18, 2024," an FDA spokesperson wrote in an email to NPR

Image Credit: siamionau pavel / Shutterstock Background Weight loss reduces obesity-related comorbidities but often leads to decreased bone mineral density (BMD) and increased bone turnover, raising fracture risk and mortality

3 That 5-percent drop is key because its the benchmark associated with meaningful improvements in blood sugar, blood pressure, and overall metabolic health

APAC is becoming ground zero for future competition China and the wider APAC region are emerging as critical arenas for GLP 1 development